Literature DB >> 14586888

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

Russell H Wiesner, Michael Sorrell, Federico Villamil.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14586888     DOI: 10.1053/jlts.2003.50268

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  80 in total

Review 1.  Mixing the right hepatitis C inhibitor cocktail.

Authors:  Michael A Gelman; Jeffrey S Glenn
Journal:  Trends Mol Med       Date:  2010-11-23       Impact factor: 11.951

2.  Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined.

Authors:  Jacqueline G O'Leary; Michael A Neri; James F Trotter; Gary L Davis; Göran B Klintmalm
Journal:  Transpl Int       Date:  2012-05-30       Impact factor: 3.782

Review 3.  Recurrent hepatitis C after liver transplant.

Authors:  Andrew S deLemos; Paul A Schmeltzer; Mark W Russo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection.

Authors:  Donna L White; Peter A Richardson; Mukhtar Al-Saadi; Stephanie J Fitzgerald; Linda Green; Chami Amaratunge; Manvir Anand; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2010-12-28       Impact factor: 3.199

Review 5.  Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Authors:  Kymberly D S Watt; Kelly Burak; Marc Deschênes; Les Lilly; Denis Marleau; Paul Marotta; Andrew Mason; Kevork M Peltekian; Eberhard L Renner; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

Review 6.  The unfinished legacy of liver transplantation: emphasis on immunology.

Authors:  Thomas E Starzl; Fadi G Lakkis
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

7.  Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.

Authors:  Vijay Subramanian; Anil B Seetharam; Neeta Vachharajani; Venkataswarup Tiriveedhi; Nataraju Angaswamy; Sabarinathan Ramachandran; Jeffrey S Crippin; Surendra Shenoy; William C Chapman; Thalachallour Mohanakumar; Christopher D Anderson
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

8.  Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease.

Authors:  Stefano Targhetta; Federico Villamil; Paolo Inturri; Patrizia Pontisso; Stefano Fagiuoli; Umberto Cillo; Attilio Cecchetto; Simona Gianni; Remo Naccarato; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

Authors:  Sinziana Dumitra; Salleh I Alabbad; Jeffrey S Barkun; Teodora C Dumitra; Dimitrios Coutsinos; Peter P Metrakos; Mazen Hassanain; Steven Paraskevas; Prosanto Chaudhury; Jean I Tchervenkov
Journal:  HPB (Oxford)       Date:  2013-03-14       Impact factor: 3.647

Review 10.  Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation.

Authors:  Jan Peveling-Oberhag; Stefan Zeuzem; Wolf Peter Hofmann
Journal:  Med Microbiol Immunol       Date:  2009-11-10       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.